COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Bavarian Nordic AS said the US government has extended a contract for development of a smallpox treatment awarded to the group in 2004.
COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Bavarian Nordic AS said the US government has extended a contract for development of a smallpox treatment awarded to the group in 2004.